#Dupuytren

What is Dupuytren Disease?
By: Charles Eaton
Jul 28, 2017

What is Dupuytren disease? After passing the first hurdle of pronouncing Dupuytren (DOOpa-tren: sort of rhymes with “hooka den”, “group of friends” “move again” “super bend”…), most people – doctors and patients alike – have trouble answering this question. Most doctors don’t give a simple answer. Instead, they often just describe some part of the problem. […]

Read more ›
Dupuytren and nerve problems?

Does Dupuytren cause nerve problems? A common topic of discussion on Dupuytren forums such The Dupuytren’s Disease Support Group is whether or not Dupuytren causes numbness and tingling in the hands and arms. As with everything Dupuytren related, the answer is …it depends. A few small studies suggesting that local tenderness in Dupuytren cords, nodules, […]

Read more ›
A Meaningful Father’s Day
On: Jun 13, 2017
By: Charles Eaton

A Meaningful Father’s Day Father’s Day is almost here, a time for family remembrance of things passed through generations. Dupuytren disease also passes through generations. A parent with Dupuytren gives each child about one in four chance of eventually having the disease. More fathers than mothers have Dupuytren disease. Dupuytren makes every Father’s Day a […]

Read more ›
How common is Dupuytren Disease?
On: Apr 1, 2017
By: Charles Eaton

How common is Dupuytren disease? The short answer is this:  much more common than you might think. Scroll to the bottom to get the summary numbers. For the long answer, keep reading. The details depend on where you get your data. One set of data comes from a large web-based survey (DiBenedetti 2010). One conclusion […]

Read more ›
Dupuytren Disease Awareness Day!
On: Mar 20, 2017
By: Charles Eaton

Dupuytren Awareness Dupuytren disease research has a big problem: lack of awareness. Most people have never heard the word “Dupuytren”, much less “Dupuytren Disease”. The name “Dupuytren” is hard to pronounce and even harder to spell. Many other medical conditions have had this problem. Most have still not made it out into public. It takes work, […]

Read more ›
Cannabinoids, Dupuytren, and Orphan Drugs
On: Mar 3, 2017
By: Charles Eaton

I was recently asked if medical marijuana might be helpful for Dupuytren disease. The short answer is “No one knows.”. The longer answer is much more interesting. The late effect of Dupuytren disease is Dupuytren contracture. The medical term for the findings in Dupuytren contracture is fibrosis. Sclerosis also means the same thing. If either of […]

Read more ›
Happy Valentine’s Day from Dupuytren Research Group!
On: Feb 14, 2017
By: Charles Eaton

Two Dupuytren stories for this Valentine’s Day. First, Saint Valentine. There were nearly a dozen people called Saint Valentine. Did this one have Dupuytren Contracture? He’s clearly in the high risk demographic – an old Caucasian man. Looks like he’s got it, but we’ll never know. It is important to know that there’s a lot […]

Read more ›
Heads and Hands: Biomarkers
On: Jan 9, 2017
By: Charles Eaton

Heads and Hands: Biomarkers Biomarkers are the focus of Dupuytren Research Group research – the International Dupuytren Data Bank. Researchers in many medical specialties are searching for biomarkers, not just to find new treatments, but as a guide to current treatment. Blood test biomarkers are under investigation for better management and eventually prevention of  post-concussive […]

Read more ›
The Future is Coming!

Improving the Future of Dupuytren Care Right now, many people with mild Dupuytren biology do well after surgery or after Xiaflex – because most people have mild to moderate Dupuytren biology. The issue isn’t the patient with mild disease biology who will do well for a long time after any treatment. The issue is those […]

Read more ›